Vertex Pharmaceuticals financial leverage is the degree to which the firm utilises its fixed-income securities. Companies with high leverage are usually considered to be at financial risk. Vertex Pharmaceuticals financial risk is the risk to Vertex Pharmaceuticals stockholders that is caused by an increase in debt. In other words with a high degree of financial leverage come high interest payments which usually reduces Earnings Per Share (EPS). Also please take a look at analysis of Vertex Pharmaceuticals Fundamentals Over Time.
Vertex Pharmaceuticals Financial Leverage Rating
Total Macroaxis Rating
Average S&P Rating
Vertex Pharmaceuticals Debt to Cash Allocation
The company currently holds 656.95 M in liabilities with Debt to Equity (D/E) ratio of 12.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vertex Pharmaceuticals has Current Ratio of 3.67 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Vertex Pharmaceuticals Inventories Over Time
Vertex Pharmaceuticals Historical Liabilities
Also Currentnly Active
Purchased over 200 shares of
Purchased over 60 shares of